The latest from Cogstate, leaders in optimizing the measurement of cognition

Education, health services appeal

May 1, 2013

AFR Small Caps writer, Jake Mitchell reported on the education and health testing services industry, featuring CogState’s computerised cognition test as one of the examples of the industry which caters to a large market opportunity in dementia and other psychological conditions. CogState’s deal with Merck Canada has also been referenced.

Mitchell states, “CogState sells its computerised cognition test to leading pharmaceutical companies around the world, which use the test to determine the cognitive effects of trial drugs.”

Read the full article here.